476 related articles for article (PubMed ID: 9649918)
41. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
Mundangepfupfu T; Waseem M
J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
[TBL] [Abstract][Full Text] [Related]
42. Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study.
Hickey M; Fraser I; Dwarte D; Graham S
Hum Reprod; 1996 Oct; 11 Suppl 2():35-44. PubMed ID: 8982744
[TBL] [Abstract][Full Text] [Related]
43. Radioimmunoassay of hCG as an early diagnosis of cerebral metastases in choriocarcinoma patients.
Soma H; Takayama M; Tokoro K; Kikuchi T; Kikuchi K; Saegusa H
Acta Obstet Gynecol Scand; 1980; 59(5):445-8. PubMed ID: 7446011
[TBL] [Abstract][Full Text] [Related]
44. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
Suvisaari J; Lähteenmäki P
Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
[TBL] [Abstract][Full Text] [Related]
45. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
46. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
47. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
Sakuragi N
Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
[No Abstract] [Full Text] [Related]
48. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
49. Role of chemotherapy and thrombolysis in treatment of choriocarcinoma accompanied with pulmonary embolism: A case report with literature review.
Yang M; Peng L
Medicine (Baltimore); 2017 Sep; 96(36):e7866. PubMed ID: 28885339
[TBL] [Abstract][Full Text] [Related]
50. Improved monitoring of gestational trophoblastic neoplasia using a highly sensitive assay for urinary human chorionic gonadotropin.
Wehmann RE; Ayala AR; Birken S; Canfield RE; Nisula BC
Am J Obstet Gynecol; 1981 Aug; 140(7):753-7. PubMed ID: 6266253
[TBL] [Abstract][Full Text] [Related]
51. Gonadotropin-releasing hormone-induced elevation of serum hCG in choriocarcinoma: a case report.
Furuhashi M; Miyabe Y; Katsumata Y; Oda H; Imai N
Endocr J; 1998 Aug; 45(4):585-90. PubMed ID: 9881911
[TBL] [Abstract][Full Text] [Related]
52. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
Witjaksono J; Lau TM; Affandi B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
[TBL] [Abstract][Full Text] [Related]
53. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
54. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
55. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception.
Runic R; Schatz F; Krey L; Demopoulos R; Thung S; Wan L; Lockwood CJ
J Clin Endocrinol Metab; 1997 Jun; 82(6):1983-8. PubMed ID: 9177417
[TBL] [Abstract][Full Text] [Related]
56. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
[TBL] [Abstract][Full Text] [Related]
57. Choriocarcinoma and partial hydatidiform moles.
Seckl MJ; Fisher RA; Salerno G; Rees H; Paradinas FJ; Foskett M; Newlands ES
Lancet; 2000 Jul; 356(9223):36-9. PubMed ID: 10892763
[TBL] [Abstract][Full Text] [Related]
58. [Typical forms of choriocarcinoma in clinical practice--diagnosis and therapeutic course in four patients].
Gurlit L; Lampe S; Goeschen K; Krech R; Hartlapp HJ; Böhmer S
Zentralbl Gynakol; 2001 Jul; 123(7):383-9. PubMed ID: 11534298
[TBL] [Abstract][Full Text] [Related]
59. Spontaneous uterine perforation of choriocarcinoma with negative beta-human chorionic gonadotropin after chemotherapy.
Xie C; Zheng L; Li ZY; Zhao X
Med Princ Pract; 2011; 20(6):570-3. PubMed ID: 21986018
[TBL] [Abstract][Full Text] [Related]
60. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
